N.Y. Education Law Section 6811-C
Patient notification of recalled drugs


1.

For purposes of this section the term “class I recall” shall mean a situation in which the United States food and drug administration deems there is reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.

2.

Where there has been a class I recall of a prescription drug, pharmacies shall make a reasonable attempt to notify all patients that have been prescribed and who are currently taking such recalled drug dispensed from such pharmacy by phone or by mail within three days of the pharmacy being notified by the United States food and drug administration, a manufacturer, a wholesaler or by other notice of such recall.

3.

The notification required by this section may be provided by an individual pharmacy or by a central office in the case of a pharmacy that is part of a chain.

Source: Section 6811-C — Patient notification of recalled drugs, https://www.­nysenate.­gov/legislation/laws/EDN/6811-C (updated Oct. 25, 2019; accessed Jun. 22, 2024).

6800
Introduction
6801
Definition of practice of pharmacy
6801‑A
Collaborative drug therapy management demonstration program
6802
Definitions
6803
Practice of pharmacy and use of title “pharmacist”
6804
State board of pharmacy
6805
Requirements for a professional license
6806
Limited permits
6807
Exempt persons
6808
Registering and operating establishments
6808‑A
Identification of Pharmacists
6808‑B
Registration of nonresident establishments
6810
Prescriptions
6811
Misdemeanors
6811‑A
Certain drugs to be clearly marked or labeled
6811‑B
Door-to-door distribution of drugs prohibited
6811‑C
Patient notification of recalled drugs
6812
Special provisions
6813
Seizure: 1
6814
Records of shipment
6815
Adulterating, misbranding and substituting
6816
Omitting to label drugs, or labeling them wrongly
6816‑A
When substitution is required
6817
New drugs
6818
Adulterated and misbranded cosmetics
6818‑A
Cosmetic samples
6819
Regulations making exceptions
6820
Certification of coal-tar colors for drugs and cosmetics
6821
Poison schedules
6822
Examinations and investigations
6823
Factory inspection
6824
Injunction proceedings
6825
Proof required in prosecution for certain violations
6826
Drug retail price lists
6826‑A
Reducing certain copayments
6827
Mandatory continuing education
6828
Certificates of administration
6829
Interpretation and translation requirements for prescription drugs and standardized medication labeling
6830
Standardized patient-centered data elements
6831
Special provisions relating to outsourcing facilities
6832
Limitations on assistance of an unlicensed person

Accessed:
Jun. 22, 2024

Last modified:
Oct. 25, 2019

§ 6811-C’s source at nysenate​.gov

Link Style